Pralatrexate in patients with recurrent or refractory peripheral T-cell lymphomas: a multicenter retrospective analysis

Peripheral T-cell lymphomas (PTCL) are a heterogeneous group of non-Hodgkin’s lymphomas with poor clinical outcomes. Pralatrexate showed efficacy and safety in recurrent or refractory PTCLs. The purpose or this study was to investigate the efficacy and safety of pralatrexate in relapsed or refractor...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Jung Yong, Yoon, Dok Hyun, Yoon, Sang Eun, Kim, Seok Jin, Lee, Ho Sup, Eom, Hyeon-Seok, Lee, Hye Won, Shin, Dong-Yeop, Koh, Youngil, Yoon, Sung-Soo, Jo, Jae-Cheol, Kim, Jin Seok, Kim, Soo-Jeong, Cho, Su-Hee, Lee, Won-Sik, Won, Jong-Ho, Kim, Won Seog, Suh, Cheolwon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6937326/
https://www.ncbi.nlm.nih.gov/pubmed/31889144
http://dx.doi.org/10.1038/s41598-019-56891-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6937326/
https://www.ncbi.nlm.nih.gov/pubmed/31889144
http://dx.doi.org/10.1038/s41598-019-56891-0

Ejemplares similares